The GA-Hecate Peptide inhibits the ZIKV Replicative Cycle in Different Steps and can Inhibit the Flavivirus NS2B-NS3 Protease after Cell Infection

Background: Peptide drugs are advantageous because they are subject to rational design and exhibit highly diverse structures and broad biological activities. The NS2B-NS3 protein is a particularly promising flavivirus therapeutic target, with extensive research on the development of inhibitors as th...

ver descrição completa

Detalhes bibliográficos
Autores: Sanches, Paulo Ricardo da Silva [UNESP], Faria, João Caldana Elias de Campos [UNESP], Bittar, Cíntia [UNESP], Olivieri, Hugo Alexandre Siqueira Guberovich [UNESP], Mesquita, Nathalya Cristina de Moraes Roso, Noske, Gabriela Dias, de Godoy, Andre Schutzer, Oliva, Glaucius, Rahal, Paula [UNESP], Cilli, Eduardo Maffud [UNESP]
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:Brasil
Recursos:Universidade Estadual Paulista (UNESP)
Repositorio:Repositório Institucional da UNESP
Idioma:inglés
OAI Identifier:oai:repositorio.unesp.br:11449/299193
Acesso em linha:http://dx.doi.org/10.2174/0109298665308871240703090408
https://hdl.handle.net/11449/299193
Access Level:acceso abierto
Palavra-chave:bioconjugate
flavivirus
NS2B-NS3
peptides
protease
Zika virus
id BR_e775b2915ed88a665c84cb9bf744a4e0
oai_identifier_str oai:repositorio.unesp.br:11449/299193
network_acronym_str BR
network_name_str Brasil
repository_id_str
spelling The GA-Hecate Peptide inhibits the ZIKV Replicative Cycle in Different Steps and can Inhibit the Flavivirus NS2B-NS3 Protease after Cell InfectionbioconjugateflavivirusNS2B-NS3peptidesproteaseZika virusBackground: Peptide drugs are advantageous because they are subject to rational design and exhibit highly diverse structures and broad biological activities. The NS2B-NS3 protein is a particularly promising flavivirus therapeutic target, with extensive research on the development of inhibitors as therapeutic candidates, and was used as a model in this work to determine the mechanism by which GA-Hecate inhibits ZIKV replication. Objective: The present study aimed to evaluate the potential of GA-Hecate, a new antiviral developed by our group, against the Brazilian Zika virus and to evaluate the mechanism of action of this compound on the flavivirus NS2B-NS3 protein. Methods: Solid-phase peptide Synthesis, High-Performance Liquid Chromatography, and Mass Spectrometry were used to obtain, purify, and characterize the synthesized compound. Real-time and enzymatic assays were used to determine the antiviral potential of GA-Hecate against ZIKV. Results: The RT-qPCR results showed that GA-Hecate decreased the number of ZIKV RNA copies in the virucidal, pre-treatment, and post-entry assays, with 5-to 6-fold fewer RNA copies at the higher nontoxic concentration in Vero cells (HNTC: 10 μM) than in the control cells. Enzymatic and kinetic assays indicated that GA-Hecate acts as a competitive ZIKV NS2B-NS3 protease inhibitor with an IC50 of 32 nM and has activity against the yellow fever virus protease. Conclusion: The results highlight the antiviral potential of the GA-Hecate bioconjugate and open the door for the development of new antivirals.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Department of Biological Science School of Pharmacy São Paulo State University (UNESP), SPDepartment of Biological Science Institute of Bioscience Letters and Exact Science São Paulo State University (UNESP), SPSão Carlos Institute of Physics University of São Paulo (USP), SPDepartment of Biochemistry and Organic Chemistry Institute of Chemistry São Paulo State University (UNESP), SPDepartment of Biological Science School of Pharmacy São Paulo State University (UNESP), SPDepartment of Biological Science Institute of Bioscience Letters and Exact Science São Paulo State University (UNESP), SPDepartment of Biochemistry and Organic Chemistry Institute of Chemistry São Paulo State University (UNESP), SPFAPESP: 15/23244-8FAPESP: 19/08342-4FAPESP: 20/05761-3FAPESP: 20/12519-4FAPESP: 2013/07600-3FAPESP: 2022/05411-8FAPESP: 2022/11644-5Universidade Estadual Paulista (UNESP)Universidade de São Paulo (USP)2025-04-29T18:41:38Z2024-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article532-543http://dx.doi.org/10.2174/0109298665308871240703090408Protein and Peptide Letters, v. 31, n. 7, p. 532-543, 2024.1875-53050929-8665https://hdl.handle.net/11449/29919310.2174/01092986653088712407030904082-s2.0-85203356662Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengProtein and Peptide Lettersinfo:eu-repo/semantics/openAccessSanches, Paulo Ricardo da Silva [UNESP]Faria, João Caldana Elias de Campos [UNESP]Bittar, Cíntia [UNESP]Olivieri, Hugo Alexandre Siqueira Guberovich [UNESP]Mesquita, Nathalya Cristina de Moraes RosoNoske, Gabriela Diasde Godoy, Andre SchutzerOliva, GlauciusRahal, Paula [UNESP]Cilli, Eduardo Maffud [UNESP]2025-05-28T05:38:46Zoai:repositorio.unesp.br:11449/299193Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462025-05-28T05:38:46Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv The GA-Hecate Peptide inhibits the ZIKV Replicative Cycle in Different Steps and can Inhibit the Flavivirus NS2B-NS3 Protease after Cell Infection
title The GA-Hecate Peptide inhibits the ZIKV Replicative Cycle in Different Steps and can Inhibit the Flavivirus NS2B-NS3 Protease after Cell Infection
spellingShingle The GA-Hecate Peptide inhibits the ZIKV Replicative Cycle in Different Steps and can Inhibit the Flavivirus NS2B-NS3 Protease after Cell Infection
Sanches, Paulo Ricardo da Silva [UNESP]
bioconjugate
flavivirus
NS2B-NS3
peptides
protease
Zika virus
title_short The GA-Hecate Peptide inhibits the ZIKV Replicative Cycle in Different Steps and can Inhibit the Flavivirus NS2B-NS3 Protease after Cell Infection
title_full The GA-Hecate Peptide inhibits the ZIKV Replicative Cycle in Different Steps and can Inhibit the Flavivirus NS2B-NS3 Protease after Cell Infection
title_fullStr The GA-Hecate Peptide inhibits the ZIKV Replicative Cycle in Different Steps and can Inhibit the Flavivirus NS2B-NS3 Protease after Cell Infection
title_full_unstemmed The GA-Hecate Peptide inhibits the ZIKV Replicative Cycle in Different Steps and can Inhibit the Flavivirus NS2B-NS3 Protease after Cell Infection
title_sort The GA-Hecate Peptide inhibits the ZIKV Replicative Cycle in Different Steps and can Inhibit the Flavivirus NS2B-NS3 Protease after Cell Infection
dc.creator.none.fl_str_mv Sanches, Paulo Ricardo da Silva [UNESP]
Faria, João Caldana Elias de Campos [UNESP]
Bittar, Cíntia [UNESP]
Olivieri, Hugo Alexandre Siqueira Guberovich [UNESP]
Mesquita, Nathalya Cristina de Moraes Roso
Noske, Gabriela Dias
de Godoy, Andre Schutzer
Oliva, Glaucius
Rahal, Paula [UNESP]
Cilli, Eduardo Maffud [UNESP]
author Sanches, Paulo Ricardo da Silva [UNESP]
author_facet Sanches, Paulo Ricardo da Silva [UNESP]
Faria, João Caldana Elias de Campos [UNESP]
Bittar, Cíntia [UNESP]
Olivieri, Hugo Alexandre Siqueira Guberovich [UNESP]
Mesquita, Nathalya Cristina de Moraes Roso
Noske, Gabriela Dias
de Godoy, Andre Schutzer
Oliva, Glaucius
Rahal, Paula [UNESP]
Cilli, Eduardo Maffud [UNESP]
author_role author
author2 Faria, João Caldana Elias de Campos [UNESP]
Bittar, Cíntia [UNESP]
Olivieri, Hugo Alexandre Siqueira Guberovich [UNESP]
Mesquita, Nathalya Cristina de Moraes Roso
Noske, Gabriela Dias
de Godoy, Andre Schutzer
Oliva, Glaucius
Rahal, Paula [UNESP]
Cilli, Eduardo Maffud [UNESP]
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (UNESP)
Universidade de São Paulo (USP)
dc.subject.por.fl_str_mv bioconjugate
flavivirus
NS2B-NS3
peptides
protease
Zika virus
topic bioconjugate
flavivirus
NS2B-NS3
peptides
protease
Zika virus
description Background: Peptide drugs are advantageous because they are subject to rational design and exhibit highly diverse structures and broad biological activities. The NS2B-NS3 protein is a particularly promising flavivirus therapeutic target, with extensive research on the development of inhibitors as therapeutic candidates, and was used as a model in this work to determine the mechanism by which GA-Hecate inhibits ZIKV replication. Objective: The present study aimed to evaluate the potential of GA-Hecate, a new antiviral developed by our group, against the Brazilian Zika virus and to evaluate the mechanism of action of this compound on the flavivirus NS2B-NS3 protein. Methods: Solid-phase peptide Synthesis, High-Performance Liquid Chromatography, and Mass Spectrometry were used to obtain, purify, and characterize the synthesized compound. Real-time and enzymatic assays were used to determine the antiviral potential of GA-Hecate against ZIKV. Results: The RT-qPCR results showed that GA-Hecate decreased the number of ZIKV RNA copies in the virucidal, pre-treatment, and post-entry assays, with 5-to 6-fold fewer RNA copies at the higher nontoxic concentration in Vero cells (HNTC: 10 μM) than in the control cells. Enzymatic and kinetic assays indicated that GA-Hecate acts as a competitive ZIKV NS2B-NS3 protease inhibitor with an IC50 of 32 nM and has activity against the yellow fever virus protease. Conclusion: The results highlight the antiviral potential of the GA-Hecate bioconjugate and open the door for the development of new antivirals.
publishDate 2024
dc.date.none.fl_str_mv 2024-01-01
2025-04-29T18:41:38Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.2174/0109298665308871240703090408
Protein and Peptide Letters, v. 31, n. 7, p. 532-543, 2024.
1875-5305
0929-8665
https://hdl.handle.net/11449/299193
10.2174/0109298665308871240703090408
2-s2.0-85203356662
url http://dx.doi.org/10.2174/0109298665308871240703090408
https://hdl.handle.net/11449/299193
identifier_str_mv Protein and Peptide Letters, v. 31, n. 7, p. 532-543, 2024.
1875-5305
0929-8665
10.2174/0109298665308871240703090408
2-s2.0-85203356662
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Protein and Peptide Letters
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 532-543
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv repositoriounesp@unesp.br
_version_ 1853671801958170624
score 15,198674